Alsius Corporation Announces Presentation at the 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
Share:
IRVINE, Calif., Jan. 23 / -- Alsius Corporation (NASDAQ:ALUS), which designs, manufactures and sells advanced patient temperature management therapies, announced today that Bill Worthen, President and Chief Executive Officer, will present a corporate update at the 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference on Wednesday, February 6, 2008.
The presentation details are as follows:
Date/Time: Wednesday, February 6, 2008, 3:20 p.m. Eastern Standard Time
Location: Ballroom B, Grand Hyatt Hotel in New York City
A live audio webcast of the presentation will be available for 14 days on the Investor Relations section of the Company's website at http://www.alsius.com/.
About Alsius
Alsius, headquartered in Irvine, CA, is a commercial-stage medical device company that develops, manufactures and sells proprietary products to precisely control patient temperature in hospital critical care settings. Controlling body temperature, through cooling and warming, is becoming the standard of care for patients in select critical conditions and those undergoing a variety of surgical procedures. Alsius markets a comprehensive suite of catheter-based intravascular temperature management products that address the need for effective, accurate, easy-to-use and cost-effective control of body temperature in critical care patients.
Alsius' products consist of the CoolGard and Thermogard systems and three families of single-use catheters. The systems are computer-controlled temperature regulation units that circulate cool or warm saline in a closed-loop through balloons that surround the catheters. Alsius' catheters are inserted into a major vein through a patient's neck or groin and achieve rapid and precise temperature management through contact with the patient's blood flow. Unlike conventional external temperature management products, such as cooling and warming blankets and ice packs, Alsius' intravascular products cool and warm the patient from the inside out, more effectively managing body temperature and allowing caregivers easier access to administer patient care. For more information, visit http://www.alsius.com/.
CONTACT: Alsius Corporation
Brett L. Scott, 949-453-0150
Chief Financial Officer
bscott@alsius.com
WeissComm Partners
Julio Cantre, 415-946-1055
jcantre@wcpglobal.com
Source: Alsius Corporation
Web site: http://www.alsius.com/
